Phage display, first described in 1985, has evolved into a well-established technology for various applications. Leveraging over 10 years of experience, Creative Biolabs has crafted an exceptional phage display platform with versatile display systems and effective biopanning strategies. Learn more: https://phagenbio.creative-biolabs.com/phage-display.htm

Drosophila melanogaster serves as a model organism for studying a wide range of topics, from basic genetics to tissue and organ development. The fruit fly's short generation time, low maintenance costs, and access to potent genetic tools make it well-suited for investigating complex pathways in biomedical research (including cancer). Learn more about Fruit flies for biomedical research: https://modelorg-ab.creative-biolabs.com/category-d-melanogaster-25.htm

Fc fusion is a highly successful strategy for extending the half-life of therapeutic proteins. It has been widely applied in developing various fusion proteins, encompassing molecules such as hormones, growth factors, blood proteins, and protein/peptide mimetics. Drawing on years of experience, Creative Biolabs provides a comprehensive technology platform for one-stop Fc-fusion development services. Learn more: https://half-life-extension.creative-biolabs.com/fc-fusion-protein-development.htm

Pancreatic Cancer is the 3rd biggest killer of all cancers (set to rise to 2nd place) and despite this, there are still no effective diagnostic tools or treatments available. Oncoparse wants to change this by developing a next-generation diagnostic assay that will use a simple blood test to determine the Tumour DNA levels in the body allowing clinicians to make agile and informed decisions on patient treatment plans. Oncoparse is currently growing and would like to invite interested parties - be it to invest, join us in the labs or share experiences - to reach out to Martin (martin@oncoparse.com).

Michelle Roberts, BBC Digital health editor reports that a man in France with advanced Parkinson's disease has been helped to walk again with a special implant that stimulates nerves in his spine.How is works:  The stimulator sits on the lumbar region of the spinal cord, which sends messages to the leg muscles.  The man in question, Marc Gauthier, is still in control - his brain gives the instructions - but the epidural implant adds electrical signals for a smoother end result.For more information: https://www.bbc.com/news/health-67295526Original research in the journal Nature Medicine:  https://rb.gy/ib6tzi